We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

76 hedge funds and large institutions have $8.75M invested in Ampio Pharmaceuticals Inc. in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

557% more call options, than puts

Call options by funds: $138K | Put options by funds: $21K

39% more capital invested

Capital invested by funds: $6.3M → $8.75M (+$2.45M)

17% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 12

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 75 → 76 (+1)

Holders
76
Holders Change
+1
Holders Change %
+1.33%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
14
Reduced
12
Closed
10
Calls
$138K
Puts
$21K
Net Calls
+$117K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$345K
2
CH
CVI Holdings
Delaware
+$240K
3
VFA
Valeo Financial Advisors
Indiana
+$235K
4
HIS
Harvest Investment Services
Illinois
+$47.1K
5
BJL
Brighton Jones LLC
Washington
+$23.9K

Top Sellers

Rank Fund Capital Flow
1
WWM
Western Wealth Management
Colorado
-$263K
2
Millennium Management
Millennium Management
New York
-$36.8K
3
Deutsche Bank
Deutsche Bank
Germany
-$22.2K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$21K
5
CCMW
Cypress Capital Management (Wyoming)
Wyoming
-$18.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
51
PNC Financial Services Group
Pennsylvania
$8K – – –
Commonwealth Equity Services
52
Commonwealth Equity Services
Massachusetts
$7K -$1.42K -11 -21%
BCM
53
Brookstone Capital Management
Illinois
$7K – – –
Group One Trading
54
Group One Trading
Illinois
$7K +$4.91K +38 +3,800%
CAL
55
Capital Analysts LLC
Pennsylvania
$6K – – –
OC
56
Oppenheimer & Co
New York
$6K – – –
CW
57
CreativeOne Wealth
Kansas
$6K +$4.78K +37 New
Northwestern Mutual Wealth Management
58
Northwestern Mutual Wealth Management
Wisconsin
$5K – – –
WA
59
WealthTrust Axiom
Pennsylvania
$5K – – –
Bank of America
60
Bank of America
North Carolina
$3K -$258 -2 -12%
LTFS
61
Ladenburg Thalmann Financial Services
Florida
$3K – – –
SCA
62
Stonebridge Capital Advisors
Minnesota
$3K – – –
CCM
63
Covington Capital Management
California
$2K – – –
RFM
64
Royal Fund Management
Florida
$2K – – –
ACM
65
Anfield Capital Management
California
$2K +$1.55K +12 New
WQ
66
Wealth Quarterback
New Jersey
$1.75K +$1.29K +10 New
AF
67
Allworth Financial
California
$1K – – –
CFG
68
Citizens Financial Group
Rhode Island
$1K – – –
CTB
69
Country Trust Bank
Illinois
$1K – – –
MA
70
MUFG Americas
New York
$1K – – –
Royal Bank of Canada
71
Royal Bank of Canada
Ontario, Canada
$1K – – –
SS
72
Sunbelt Securities
Texas
$1K – – –
VCP
73
Verus Capital Partners
Arizona
$1K +$904 +7 New
GEA
74
Glen Eagle Advisors
New Jersey
$583 – – –
BNP Paribas Financial Markets
75
BNP Paribas Financial Markets
France
$400 -$5.04K -39 -95%
1 2
3
4

AMPE Hedge Fund Activity: Q4 2019 in Review

76 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2019, worth a combined $8.75M — up 39% from $6.3M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AMPE positions and 10 closed out — a net gain of 1 holder — while 14 added to existing stakes and 12 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $345K. The largest seller was Western Wealth Management, exiting entirely with an estimated $263K sold.

  • 76 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2019, up from 75 in Q3 2019.
  • Funds reported $8.75M of Ampio Pharmaceuticals Inc. stock for Q4 2019, up 39% quarter-over-quarter.
  • 11 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2019 and 10 closed out, a net change of +1 holder.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q4 2019 was Susquehanna International Group, an estimated $345K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q4 2019 was Western Wealth Management, an estimated $263K sold.

Based on aggregated 13F filings for Q4 2019.